코르버스 파마슈티컬스 홀딩스, Inc.
DE ˙ DB ˙ US21833P3010
€6.38 0.00 (0.00%)
2026-06-04
주가
SecurityDE:3371 / Corbus Pharmaceuticals Holdings, Inc.
InstitutionGroup One Trading, L.p.
Latest Disclosed Ownership6,586 shares
Latest Disclosed Value $ 53,610
Group One Trading, L.p. ownership in 3371 / Corbus Pharmaceuticals Holdings, Inc.

On February 11, 2026 - Group One Trading, L.p. filed a 13F-HR form disclosing ownership of 6,586 shares of Corbus Pharmaceuticals Holdings, Inc. (DE:3371) valued at $43,797 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 12, 2025 disclosing 6,030 shares of Corbus Pharmaceuticals Holdings, Inc.. This represents a change in shares of 9.22% during the quarter. The current value of the position is $41,986 USD.

Group One Trading, L.p. has a history of taking positions in derivatives of the underlying security (3371) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:3371 / Corbus Pharmaceuticals Holdings, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-11 2025-12-31 13F CORBUS PHARMACEUTICALS HLDGS COM NEW 21833P301 6,586 556 9.22 54 -30.26 0.0001
2025-11-12 2025-09-30 13F CORBUS PHARMACEUTICALS HLDGS COM NEW 21833P301 6,030 6,030 76 0.0001
2025-05-14 2025-03-31 13F CORBUS PHARMACEUTICALS HLDGS COM NEW 21833P301 0 -8,158 -100.00 0 -100.00
2025-05-14 2024-12-31 13F/A-1 CORBUS PHARMACEUTICALS HLDGS COM NEW 21833P301 8,158 8,158 96 0.0002
2025-02-14 2024-12-31 13F CORBUS PHARMACEUTICALS HLDGS COM NEW 21833P301 8,158 8,158 96 0.0002
2024-08-14 2024-06-30 13F CORBUS PHARMACEUTICALS HLDGS COM NEW 21833P301 0 -401 -100.00 0 -100.00
2024-05-10 2024-03-31 13F CORBUS PHARMACEUTICALS HLDGS COM NEW 21833P301 401 -1,399 -77.72 16 50.00 0.0001
2024-02-14 2023-12-31 13F CORBUS PHARMACEUTICALS HLDGS COM NEW 21833P301 1,800 -230 -11.33 11 -23.08 0.0000
2023-11-09 2023-09-30 13F CORBUS PHARMACEUTICALS HLDGS COM NEW 21833P301 2,030 -15 -0.73 14 -18.75 0.0000
2023-08-09 2023-06-30 13F CORBUS PHARMACEUTICALS HLDGS COM NEW 21833P301 2,045 -220 -9.71 16 0.00 0.0001
2023-05-12 2023-03-31 13F CORBUS PHARMACEUTICALS HLDGS COM NEW 21833P301 2,265 2,265 16 0.0001
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2023-05-12 2023-03-31 13F CORBUS PHARMACEUTICALS HLDGS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-02-09 2022-12-31 13F CORBUS PHARMACEUTICALS HLDGS COM Call 22,700 -0.44 3 -50.00 n/a n/a n/a
2022-11-09 2022-09-30 13F CORBUS PHARMACEUTICALS HLDGS COM Call 22,800 0.00 4 -33.33 n/a n/a n/a
2022-08-11 2022-06-30 13F CORBUS PHARMACEUTICALS HLDGS COM Call 22,800 -17.99 6 -60.00 n/a n/a n/a
2022-05-12 2022-03-31 13F CORBUS PHARMACEUTICALS HLDGS COM Call 27,800 -72.42 15 -75.81 n/a n/a n/a
2022-02-11 2021-12-31 13F CORBUS PHARMACEUTICALS HLDGS COM Call 100,800 -37.00 62 -61.96 n/a n/a n/a
2021-11-12 2021-09-30 13F CORBUS PHARMACEUTICALS HLDGS COM Call 160,000 -11.41 163 -50.76 n/a n/a n/a
2021-08-10 2021-06-30 13F CORBUS PHARMACEUTICALS HLDGS COM Call 180,600 -10.19 331 -16.41 n/a n/a n/a
2021-05-12 2021-03-31 13F CORBUS PHARMACEUTICALS HLDGS COM Call 201,100 -37.89 396 -2.22 n/a n/a n/a
2021-02-10 2020-12-31 13F CORBUS PHARMACEUTICALS HLDGS COM Call 323,800 -21.52 405 -45.49 n/a n/a n/a
2020-11-12 2020-09-30 13F CORBUS PHARMACEUTICALS HLDGS COM Call 412,600 41.40 743 -69.65 n/a n/a n/a
2020-08-13 2020-06-30 13F CORBUS PHARMACEUTICALS HLDGS COM Call 291,800 19.84 2,448 91.85 n/a n/a n/a
2020-05-13 2020-03-31 13F CORBUS PHARMACEUTICALS HLDGS COM Call 243,500 5,562.79 1,276 5,447.83 n/a n/a n/a
2020-02-10 2019-12-31 13F CORBUS PHARMACEUTICALS HLDGS COM Call 4,300 -28.33 23 -20.69 n/a n/a n/a
2019-11-12 2019-09-30 13F CORBUS PHARMACEUTICALS HLDGS COM Call 6,000 -52.38 29 -66.67 n/a n/a n/a
2019-08-09 2019-06-30 13F CORBUS PHARMACEUTICALS HLDGS COM Call 12,600 -50.97 87 -51.40 n/a n/a n/a
2019-05-14 2019-03-31 13F/A CORBUS PHARMACEUTICALS HLDGS COM Call 25,700 -35.10 179 -22.51 n/a n/a n/a
2019-05-13 2019-03-31 13F CORBUS PHARMACEUTICALS HLDGS COM Call 25,700 179 n/a n/a n/a
2019-02-05 2018-12-31 13F CORBUS PHARMACEUTICALS HLDGS COM Call 39,600 39.44 231 7.94 n/a n/a n/a
2018-11-08 2018-09-30 13F CORBUS PHARMACEUTICALS HLDGS COM Call 28,400 317.65 214 529.41 n/a n/a n/a
2018-08-13 2018-06-30 13F CORBUS PHARMACEUTICALS HLDGS COM Call 6,800 21.43 34 0.00 n/a n/a n/a
2018-05-16 2018-03-31 13F/A CORBUS PHARMACEUTICALS HLDGS COM Call 5,600 -81.27 34 -83.96 n/a n/a n/a
2018-05-10 2018-03-31 13F CORBUS PHARMACEUTICALS HLDGS COM Call 5,600 34 n/a n/a n/a
2018-02-09 2017-12-31 13F CORBUS PHARMACEUTICALS HLDGS COM Call 29,900 -82.38 212 -82.52 n/a n/a n/a
2017-11-15 2017-09-30 13F CORBUS PHARMACEUTICALS HLDGS COM Call 169,700 -37.31 1,213 -28.86 n/a n/a n/a
2017-08-14 2017-06-30 13F CORBUS PHARMACEUTICALS HLDGS COM Call 270,700 -46.24 1,705 -58.96 n/a n/a n/a
2017-05-10 2017-03-31 13F CORBUS PHARMACEUTICALS HLDGS COM Call 503,500 1,636.21 4,154 1,595.51 n/a n/a n/a
2017-02-15 2016-12-31 13F CORBUS PHARMACEUTICALS HLDGS COM Call 29,000 -71.37 245 -64.39 n/a n/a n/a
2016-11-14 2016-09-30 13F CORBUS PHARMACEUTICALS HLDGS COM Call 101,300 688 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2023-05-12 2023-03-31 13F CORBUS PHARMACEUTICALS HLDGS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-02-09 2022-12-31 13F CORBUS PHARMACEUTICALS HLDGS COM Put 59,300 -11.09 7 -45.45 n/a n/a n/a
2022-11-09 2022-09-30 13F CORBUS PHARMACEUTICALS HLDGS COM Put 66,700 -10.47 11 -42.11 n/a n/a n/a
2022-08-11 2022-06-30 13F CORBUS PHARMACEUTICALS HLDGS COM Put 74,500 231.11 19 58.33 n/a n/a n/a
2022-05-12 2022-03-31 13F CORBUS PHARMACEUTICALS HLDGS COM Put 22,500 -55.88 12 -61.29 n/a n/a n/a
2022-02-11 2021-12-31 13F CORBUS PHARMACEUTICALS HLDGS COM Put 51,000 46.55 31 -13.89 n/a n/a n/a
2021-11-12 2021-09-30 13F CORBUS PHARMACEUTICALS HLDGS COM Put 34,800 -51.53 36 -72.52 n/a n/a n/a
2021-08-10 2021-06-30 13F CORBUS PHARMACEUTICALS HLDGS COM Put 71,800 8.46 131 0.77 n/a n/a n/a
2021-05-12 2021-03-31 13F CORBUS PHARMACEUTICALS HLDGS COM Put 66,200 257.84 130 465.22 n/a n/a n/a
2021-02-10 2020-12-31 13F CORBUS PHARMACEUTICALS HLDGS COM Put 18,500 -96.46 23 -97.56 n/a n/a n/a
2020-11-12 2020-09-30 13F CORBUS PHARMACEUTICALS HLDGS COM Put 522,800 167.97 941 -42.52 n/a n/a n/a
2020-08-13 2020-06-30 13F CORBUS PHARMACEUTICALS HLDGS COM Put 195,100 176.74 1,637 343.63 n/a n/a n/a
2020-05-13 2020-03-31 13F CORBUS PHARMACEUTICALS HLDGS COM Put 70,500 257.87 369 241.67 n/a n/a n/a
2020-02-10 2019-12-31 13F CORBUS PHARMACEUTICALS HLDGS COM Put 19,700 -59.55 108 -54.43 n/a n/a n/a
2019-11-12 2019-09-30 13F CORBUS PHARMACEUTICALS HLDGS COM Put 48,700 -22.08 237 -45.27 n/a n/a n/a
2019-08-09 2019-06-30 13F CORBUS PHARMACEUTICALS HLDGS COM Put 62,500 -33.30 433 -33.49 n/a n/a n/a
2019-05-14 2019-03-31 13F/A CORBUS PHARMACEUTICALS HLDGS COM Put 93,700 -18.66 651 -3.27 n/a n/a n/a
2019-05-13 2019-03-31 13F CORBUS PHARMACEUTICALS HLDGS COM Put 93,700 651 n/a n/a n/a
2019-02-05 2018-12-31 13F CORBUS PHARMACEUTICALS HLDGS COM Put 115,200 35.21 673 4.67 n/a n/a n/a
2018-11-08 2018-09-30 13F CORBUS PHARMACEUTICALS HLDGS COM Put 85,200 508.57 643 805.63 n/a n/a n/a
2018-08-13 2018-06-30 13F CORBUS PHARMACEUTICALS HLDGS COM Put 14,000 -72.71 71 -77.32 n/a n/a n/a
2018-05-16 2018-03-31 13F/A CORBUS PHARMACEUTICALS HLDGS COM Put 51,300 6.88 313 -8.21 n/a n/a n/a
2018-05-10 2018-03-31 13F CORBUS PHARMACEUTICALS HLDGS COM Put 51,300 313 n/a n/a n/a
2018-02-09 2017-12-31 13F CORBUS PHARMACEUTICALS HLDGS COM Put 48,000 -78.38 341 -78.51 n/a n/a n/a
2017-11-15 2017-09-30 13F CORBUS PHARMACEUTICALS HLDGS COM Put 222,000 -25.38 1,587 -15.31 n/a n/a n/a
2017-08-14 2017-06-30 13F CORBUS PHARMACEUTICALS HLDGS COM Put 297,500 -38.33 1,874 -52.91 n/a n/a n/a
2017-05-10 2017-03-31 13F CORBUS PHARMACEUTICALS HLDGS COM Put 482,400 228.61 3,980 220.97 n/a n/a n/a
2017-02-15 2016-12-31 13F CORBUS PHARMACEUTICALS HLDGS COM Put 146,800 995.52 1,240 1,262.64 n/a n/a n/a
2016-11-14 2016-09-30 13F CORBUS PHARMACEUTICALS HLDGS COM Put 13,400 91 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.